KLK3 and prostate carcinoma: The clusters isolated from the first patient expressed AR, KLK3 (PSA), or FOLH1(PSMA), displaying a profile similar to androgen-responsive LNCaP cells sequenced as one of the positive controls for prostate cancer cells.